The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. GlaxoSmithKline Pakistan's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for GlaxoSmithKline Pakistan's Dividend Payout Ratio or its related term are showing as below:
KAR:GLAXO'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.4 Med: 0.54 Max: 0.95
Current: 0.46
During the past 13 years, the highest Dividend Payout Ratio of GlaxoSmithKline Pakistan was 0.95. The lowest was 0.40. And the median was 0.54.
KAR:GLAXO's Dividend Payout Ratio is ranked worse than 62.16% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs KAR:GLAXO: 0.46
During the past 13 years, the highest Trailing Annual Dividend Yield of GlaxoSmithKline Pakistan was 9.69%. The lowest was 1.51%. And the median was 4.07%.
During the past 3 years, the average Dividends Per Share Growth Rate was 28.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GlaxoSmithKline Pakistan was 37.00% per year. The lowest was -22.80% per year. And the median was 3.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
GlaxoSmithKline Pakistan (KAR:GLAXO) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
GlaxoSmithKline Pakistan Dividend Payout Ratio Related Terms
GlaxoSmithKline Pakistan Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for GlaxoSmithKline Pakistan's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Pakistan Dividend Payout Ratio Chart
KAR:GLAXO vs ZTS, UTHR, VTRS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, GlaxoSmithKline Pakistan's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GlaxoSmithKline Pakistan Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pakistan's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where GlaxoSmithKline Pakistan's Dividend Payout Ratio falls into.
GlaxoSmithKline Pakistan Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
GlaxoSmithKline Pakistan's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Pakistan (KAR:GLAXO) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on GlaxoSmithKline Pakistan and its competitors. Over the past decade, GlaxoSmithKline Pakistan's Dividend Payout Ratio has ranged from 0.40 to 0.95. According to the industry distribution chart, GlaxoSmithKline Pakistan ranks #276 out of 444 companies in the Drug Manufacturers industry, placing it in the top 62.2%.
Is GlaxoSmithKline Pakistan's Dividend Payout Ratio too high?
GlaxoSmithKline Pakistan's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 0.95. Based on the distribution chart, GlaxoSmithKline Pakistan ranks #276 out of 444 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, GlaxoSmithKline Pakistan has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GlaxoSmithKline Pakistan's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, GlaxoSmithKline Pakistan ranks #276 out of 444 companies for Dividend Payout Ratio. This places GlaxoSmithKline Pakistan in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, GlaxoSmithKline Pakistan's own Dividend Payout Ratio has ranged from 0.40 to 0.95 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on GlaxoSmithKline Pakistan and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GlaxoSmithKline Pakistan's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline Pakistan stock overvalued right now?
Based on GuruFocus' analysis, GlaxoSmithKline Pakistan (KAR:GLAXO) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨324.26, compared to a current price of ₨370.25 — trading 14.2% above its estimated fair value. The current Dividend Payout Ratio is 0.00. GlaxoSmithKline Pakistan's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For GlaxoSmithKline Pakistan (KAR:GLAXO), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GlaxoSmithKline Pakistan (KAR:GLAXO) Overvalued in 2026?
Based on GuruFocus' analysis, GlaxoSmithKline Pakistan stock appears to be overvalued.
The current stock price of ₨370.25 is trading 14.2% above its estimated GF Value™ of ₨324.26.
GuruFocus considers GlaxoSmithKline Pakistan to be Modestly Overvalued.
Key valuation signals for KAR:GLAXO:
Dividend Payout Ratio: 0.00
GF Value™: ₨324.26 vs. price of ₨370.25 (14.2% above fair value)
No single metric tells the full story. See the KAR:GLAXO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GlaxoSmithKline Pakistan Ltd is engaged in the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. It is involved in Anti-infective, Respiratory, Vaccines, Dermatological, Gastrointestinal, Analgesics, Urology, Central Nervous System, Allergy, Cardiovascular, and Vitamins therapy areas. The operating business divisions are Pharmaceuticals and Consumer Healthcare. The pharmaceutical brands of the company include Augmentin, Seretide, Amoxicillin, Velosef, Zantac, and Calpol, and prominent vaccines include Synflorix, Infanrix Hexa, Rotarix, Engerix-B, Havrix, and Cervarix. The company operates in single segment which is the Pharmaceuticals segment.
92GF Score
Get the complete analysis for KAR:GLAXO
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:GLAXO has been successfully added to your 
